✦ LIBER ✦

Cerebral tuberculoma in a patient receiving anti-TNF alpha (adalimumab) treatment

✍ Scribed by Karen Lynch; Michael Farrell

Publisher: Springer
Year: 2010
Tongue: English
Weight: 173 KB
Volume: 29
Category: Article
ISSN: 0770-3198
DOI: 10.1007/s10067-010-1466-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aseptic meningitis in a patient receivin

Aseptic meningitis in a patient receiving treatment with anti-tumour necrosis factor alpha

✍ Alexander J. Hamilton; Nicholas J. Gutowski 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 119 KB

Atypical infectious mononucleosis in a p

Atypical infectious mononucleosis in a patient receiving tumor necrosis factor alpha inhibitory treatment

✍ Ismail Sari; Merih Birlik; Servet Akar; Fatos Onen; Aydanur Kargı; Nurullah Akko 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 170 KB

Clinical remission and/or minimal diseas

Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study

✍ Burmester, Gerd R. ;Ferraccioli, Gianfranco ;Flipo, René-Marc ;Monteagudo-Sáez, 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

Development of myeloperoxidase-antineutr

Development of myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis in a patient receiving treatment with anti-tumor necrosis factor-α

✍ Daigoro Hirohama; Junichi Hoshino; Eiko Hasegawa; Masayuki Yamanouchi; Noriko Ha 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 219 KB

Infliximab, a TNF-alpha antagonist treat

Infliximab, a TNF-alpha antagonist treatment in patients with ankylosing spondylitis: the impact on depression, anxiety and quality of life level

✍ I. Ertenli; S. Ozer; S. Kiraz; S. B. Apras; A. Akdogan; O. Karadag; M. Calguneri 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 235 KB

Radiographic, clinical, and functional o

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo-controlled, 52-week trial

✍ Edward C. Keystone; Arthur F. Kavanaugh; John T. Sharp; Hyman Tannenbaum; Ye Hua 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 2 views